TITLE

Intermittent Subcutaneous Opioids for the Management of Cancer Pain

AUTHOR(S)
Parsons, Henrique A.; Shukkoor, Abdul; Hue Quan; Delgado-Guay, Marvin O.; Palmer, J. Lynn; Fainsinger, Robin; Bruera, Eduardo
PUB. DATE
December 2008
SOURCE
Journal of Palliative Medicine;Dec2008, Vol. 11 Issue 10, p1319
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers information regarding the proper medical utilization of pain reliever opioids on cancer pain. It tackles intermittent subcutaneous (SC) opioids which is distributed among cancer patients. It also features the medical apparatus, Edmonton Symptom Assessment System (ESAS), used to manage cancer pain.
ACCESSION #
35886643

 

Related Articles

  • Survey on the use of buprenorphine patches in the palliative care practice. Bourne, Flora M.; Zylicz, Zbigniew // Advances in Palliative Medicine;2010, Vol. 9 Issue 2, p39 

    Transdermal buprenorphine is a new formulation of the old drug available for the treatment of cancer and non-cancer pain. The drug offers number of interesting new features and was found effective in clinical trials in cancer patients with pain. We performed a survey of the use of buprenorphine...

  • Implementing Therapy With Opioids in Patients With Cancer. De Leon-Casasola, Oscar // Oncology Nursing Forum;Nov2008 Supplement, Vol. 35, p7 

    Purpose/Objectives: To review strategies to optimize the management of chronic pain in patients with cancer, with an emphasis on the role of opioid analgesics.Data Sources: Published research, articles from a literature review, and U. S. statistics.Data Synthesis: Treatment for cancer pain...

  • BARRIERS TO PAIN ASSESSMENT AND MANAGEMENT. Sun, Virginia; Borneman, Tami; Ferrell, Betty; Piper, Barbara; Koczywas, Marianna; Uman, Gwen // Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p169 

    Major deficiencies in the management of cancer-related pain have been documented over the past two decades. These deficiencies to optimum pain relief are related to patient, professional, and system barriers as identified by the NIH Symptom Management Consensus Conference. This NCI supported...

  • The A, B, C, Ds of Opioid Prescribing for People Living with Cancer. INGRAM, CORY; DEMING, JIM; BOCK, ANDY // Minnesota Medicine;Sep2015, Vol. 98 Issue 9, p44 

    The article discusses guidelines for effective and safe opioid prescribing by primary care physicians for people experiencing cancer-related pain. Topics discussed include the importance of pain management to cancer patients, process of opioid naivety assessment, administration of a breakthrough...

  • Overdoses in Patients on Opioids: Risks Associated with Mental Health Conditions and Their Treatment. Bair, Matthew; Bohnert, Amy // JGIM: Journal of General Internal Medicine;Aug2015, Vol. 30 Issue 8, p1051 

    The article presents a study that investigates the risks and implications of opioid overdose in patients with mental health disorders. The topics discussed include the effectiveness of opioid therapy in the treatment of pain among cancer patients, the side-effects of opioid therapy, and the...

  • LINKING PAIN KNOWLEDGE, ASSESSMENT, MANAGEMENT, AND PATIENT OUTCOME. Wells, Nancy; McDowell, Rachel; Hendricks, Patricia // Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p170 

    Knowledge deficits are frequently cited as a barrier to adequate pain management. Guidelines exist to provide direction to providers. Linking provider knowledge to behaviors supporting good pain management and patient outcomes has proven difficult. The purpose of this study was to examine the...

  • Management of cancer pain: I. Wider implications of orthodox analgesics. Lee, Susannah K.; Dawson, Jill; Lee, Jack A.; Osman, Gizem; Levitin, Maria O.; Guzel, Refika Mine; Djamgoz, Mustafa B. A. // International Journal of General Medicine;2014, Vol. 7, p49 

    In this review, the first of two parts, we first provide an overview of the orthodox analgesics used commonly against cancer pain. Then, we examine in more detail the emerging evidence for the potential impact of analgesic use on cancer risk and disease progression. Increasing findings suggest...

  • The PRO-SELF© Pain Control Program Improves Patients' Knowledge of Cancer Pain Management. Jung-Eun Kim; Dodd, Marylin; West, Claudia; Paul, Steven; Facione, Noreen; Schumacher, Karen; Tripathy, Debu; Koo, Peter; Miaskowski, Christine // Oncology Nursing Forum;Nov2004, Vol. 31 Issue 6, p1137 

    Purpose/Objectives: To evaluate the effectiveness of a psychoeducational program (i.e., PRO-SELF© Pain Control Program) compared to standard care in increasing patients' knowledge regarding cancer pain management. Design: Randomized clinical trial. Setting: Seven outpatient settings in...

  • THE USE OF RESPONDER ANALYSIS TO IDENTIFY DIFFERENCES IN PATIENT OUTCOMES FOLLOWING A SELF- CARE INTERVENTION TO IMPROVE CANCER PAIN MANAGEMENT. Edrington, Janet; Miaskowski, Christine; Dodd, Marylin; West, Claudia; Paul, Steven M.; Schumacher, Karen // Oncology Nursing Forum;Jan2007, Vol. 34 Issue 1, p169 

    The undertreatment of cancer pain remains a significant clinical problem. Many of the educational interventions have not produced clinically significant results. Previously, we demonstrated, in a randomized clinical trial, the effectiveness of a psychoeducational intervention, to decrease pain...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics